China SXT Pharmaceuticals (China SXT Pharmaceuticals) Total Liabilities : $9.51 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Total Liabilities?

China SXT Pharmaceuticals's Total Liabilities for the quarter that ended in Sep. 2023 was $9.51 Mil.

China SXT Pharmaceuticals's quarterly Total Liabilities increased from Sep. 2022 ($7.29 Mil) to Mar. 2023 ($14.86 Mil) but then declined from Mar. 2023 ($14.86 Mil) to Sep. 2023 ($9.51 Mil).

China SXT Pharmaceuticals's annual Total Liabilities declined from Mar. 2021 ($18.59 Mil) to Mar. 2022 ($17.12 Mil) and declined from Mar. 2022 ($17.12 Mil) to Mar. 2023 ($14.86 Mil).

China SXT Pharmaceuticals Total Liabilities Historical Data

The historical data trend for China SXT Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Total Liabilities Chart

China SXT Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

6.36

12.30

18.59

17.12

14.86

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Liabilities	Get a 7-Day Free Trial									8.88	17.12	7.29	14.86	9.51

China SXT Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

China SXT Pharmaceuticals's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.497	+	(0.366	+	-3.3306690738755E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	14.86

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	29.554	-	14.691
	=	14.86

China SXT Pharmaceuticals's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.2	+	(0.312	+	1.1657341758564E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	9.51

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	14.588	-	5.076
	=	9.51

China SXT Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

2RY0:Germany

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.